About Dr. Zhang Ruiyan
Dr. Zhang Ruiyan (张瑞岩) is one of China's leading interventional cardiologists and the current Director of the Department of Cardiology at Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. He holds the title of Chief Physician and Professor and carries forward the legendary legacy of Academician Chen Haozhu as the clinical leader of one of China's most storied cardiology departments.
Dr. Zhang is nationally recognized for his expertise in complex coronary intervention, structural heart disease, and atrial fibrillation management. He has been instrumental in bringing the latest interventional cardiology techniques — including transcatheter aortic valve replacement (TAVR), left atrial appendage occlusion (LAAO), and complex bifurcation PCI — to Ruijin Hospital, establishing it as one of Shanghai's premier structural heart disease centers.
International patients with coronary artery disease, valvular heart disease, atrial fibrillation, or heart failure seeking expert cardiovascular care in Shanghai consistently identify Dr. Zhang as one of the city's top cardiologists for both primary treatment and second opinions.
Professional Positions and Affiliations
- Director, Department of Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
- Vice Chairman, Interventional Cardiology Committee, Chinese Society of Cardiology
- Member, Structural Heart Disease Committee, Chinese Society of Cardiology
- Editorial Board Member: Chinese Journal of Cardiology, Chinese Circulation Journal
- Fellow, Society for Cardiovascular Angiography and Interventions (SCAI)
- Fellow, European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Specialties and Clinical Expertise
- Complex Coronary Intervention (PCI) — left main disease, bifurcation lesions, chronic total occlusion (CTO) recanalization, calcified lesions with rotational atherectomy; intravascular imaging-guided PCI (IVUS, OCT)
- Transcatheter Aortic Valve Replacement (TAVR) — transfemoral and alternative access TAVR for severe aortic stenosis; valve-in-valve procedures for failed surgical bioprostheses
- Left Atrial Appendage Occlusion (LAAO) — Watchman and Amulet device implantation for AF patients with contraindications to anticoagulation
- MitraClip and Transcatheter Mitral Valve Repair — for functional and degenerative mitral regurgitation in high-surgical-risk patients
- Atrial Fibrillation — catheter ablation (pulmonary vein isolation, posterior wall isolation), antiarrhythmic drug optimization, and rhythm vs. rate control strategy
- Heart Failure — advanced heart failure management, cardiac resynchronization therapy (CRT), ICD implantation, and LVAD evaluation
- Coronary Imaging and Physiology — IVUS, OCT, FFR, iFR for lesion assessment and PCI optimization
- Hypertension and Preventive Cardiology — resistant hypertension workup, renal denervation, and cardiometabolic risk management
Academic and Research Contributions
Dr. Zhang Ruiyan has published over 180 peer-reviewed papers in leading international cardiology journals, with a particular focus on complex coronary intervention outcomes, intravascular imaging-guided PCI, and transcatheter structural heart disease procedures in Chinese patients. His research on CTO recanalization techniques and outcomes in Chinese patients has been widely cited and has contributed to the development of national CTO intervention guidelines.
He has led or co-led multiple multicenter trials evaluating TAVR outcomes in Chinese patients with bicuspid aortic valve — a condition more prevalent in Asian populations than in Western cohorts — and has contributed pivotal data on the safety and efficacy of LAAO in Chinese AF patients. He is a regular invited speaker at TCT (Transcatheter Cardiovascular Therapeutics), EuroPCR, and the Chinese Interventional Cardiology Congress (CICC).
Hospital: Ruijin Hospital Cardiology Department
Under Dr. Zhang's leadership, Ruijin Hospital's Cardiology Department operates:
- Three state-of-the-art Cardiac Catheterization Laboratories with biplane imaging and intravascular imaging capability
- A dedicated Structural Heart Disease Program performing TAVR, MitraClip, LAAO, and ASD/PFO closure
- A 24/7 Primary PCI Program for acute myocardial infarction with door-to-balloon times consistently below 60 minutes
- A Heart Failure Unit with advanced hemodynamic monitoring and LVAD capability
- A Cardiac Electrophysiology Laboratory with 3D mapping systems for complex ablation procedures
- A Cardiac Imaging Center with echocardiography, cardiac CT, and cardiac MRI
Why International Patients Choose Dr. Zhang Ruiyan
- Successor to Academician Chen Haozhu — leading one of China's most historically significant cardiology departments
- Complex PCI expertise — CTO, left main, bifurcation, and calcified lesion intervention with intravascular imaging guidance
- Structural heart disease pioneer — TAVR, MitraClip, and LAAO at the highest technical level
- SCAI and EAPCI Fellow — internationally credentialed and aligned with global interventional cardiology standards
- Bicuspid aortic valve TAVR expertise — particularly relevant for Asian patients where bicuspid anatomy is more common
- English-language support available through CMCS concierge coordination
Practical Information for International Patients
- Hospital: Ruijin Hospital, 197 Ruijin Er Road, Huangpu District, Shanghai
- Appointment Lead Time: 2–4 weeks for elective consultations; acute cardiac emergencies managed 24/7
- Languages: Mandarin Chinese; English interpretation provided by CMCS
- Pre-consultation: Overseas ECG, echocardiography, coronary CT, and catheterization reports can be reviewed remotely through CMCS
How CMCS Can Help
China Medical Concierge Shanghai (CMCS) provides end-to-end support for international patients seeking cardiovascular care with Dr. Zhang Ruiyan at Ruijin Hospital. Our services include priority appointment booking, medical record and imaging report translation, remote pre-consultation review, on-site interpretation, accommodation coordination, insurance liaison, and post-treatment follow-up with your home country cardiologist.
📧 Contact us: contract@medicalsh.com
💬 WeChat: gezhanglao
🌐 medicalsh.com
0 commenti